AI Insight
Researchers developed GLEAM (Galaxy Learning and Modeling), a web-based toolkit that enables biomedical researchers to perform machine learning analyses without coding expertise. The software standardizes key steps including data partitioning, model selection, training, and evaluation while supporting tabular, image, and multimodal datasets. Validation on three biomedical tasks—immunotherapy response prediction, skin lesion classification, and cancer recurrence prediction—demonstrated that GLEAM produces accurate models while improving reproducibility and analytical rigor.
Why it matters
This toolkit democratizes machine learning for biomedical researchers who lack computational programming skills, potentially accelerating research across diverse clinical applications. By standardizing methodology and ensuring reproducibility through the Galaxy platform, GLEAM addresses critical quality control issues that often undermine machine learning studies in biomedicine.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Machine learning is increasingly central to biomedical research, but using machine learning well often requires substantial computational expertise and methodological care to produce high-quality results. To make machinelearning tools more accessible to biomedical researchers while supporting best-practice approaches, we developed the Galaxy Learning and Modeling (GLEAM) software toolkit. GLEAM enables researchers to performsupervised machine learning analyses through a set of web-based, code-free software tools for tabular, image, and multimodal biomedical datasets. GLEAM standardizes data partitioning, model selection, training, evaluation,and reporting, helping researchers apply machine learning with greater rigor and consistency. GLEAM runs on the Galaxy computational workbench and uses Galaxy’s core features to make all analyses accessible,reproducible, and scalable. We validated GLEAM on three biomedical tasks: predicting patient response to immunotherapy, skin lesion classification, and cancer recurrence prediction. Across these tasks, GLEAM producedhighly accurate predictive models and improved transparency, reproducibility, and rigor.